LLY's explosive GLP-1 growth, deep obesity pipeline and strong estimate momentum give it the edge over MRK despite a richer ...
Abivax stock skyrocketed in July after the company announced overwhelmingly positive topline results from its Phase 3 ...
An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...
Zacks Investment Research on MSN
LLY trading above 50 & 200-day SMAs for 2 months: How to play the stock
Eli Lilly and Company’s LLY stock has been consistently trading above its 50-day and 200-day simple moving averages (SMAs) ...
Stocktwits on MSN
Capricor’s red-hot rally has Wall Street and retail hooked — and fresh DMD data could keep fueling the fire
H.C. Wainwright conservatively expects approval by the middle of 2026 and sees the shares trading well into the year-end.
Intellia Therapeutics, Inc. is rated Hold due to safety concerns after a patient death in its Phase 3 MAGNITUDE trial for ATTR-CM. NTLA's CRISPR/Cas9 gene editing offers potentially best-in-class, one ...
As Chief Editor of one of the two journals in which Biopharma Dealmakers appears, I have a keen interest in the process of translating biomedical research into new drugs, including the partnerships ...
Verve has hired Amanda Lie as an agent on their talent team, Variety has learned exclusively. Lie joins Verve from M88, where she worked as a talent manager since December 2024. Prior to that, she was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback